BCSH/BSBMT/UK clinical virology network guideline: diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation. (Q40721939)

From Wikidata

Jump to navigation Jump to search

scientific article published on 7 April 2016

Language	Label	Description	Also known as
English	BCSH/BSBMT/UK clinical virology network guideline: diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation.	scientific article published on 7 April 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27060988 AND SRC:MED&resulttype=core&format=json

1 April 2020

BCSH/BSBMT/UK clinical virology network guideline: diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27060988 AND SRC:MED&resulttype=core&format=json

1 April 2020

0 references

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27060988 AND SRC:MED&resulttype=core&format=json

1 April 2020

Antonio Pagliuca

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27060988 AND SRC:MED&resulttype=core&format=json

1 April 2020

author name string

Fiona L Dignan

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27060988 AND SRC:MED&resulttype=core&format=json

1 April 2020

Andrew Clark

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27060988 AND SRC:MED&resulttype=core&format=json

1 April 2020

Celia Aitken

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27060988 AND SRC:MED&resulttype=core&format=json

1 April 2020

Vishal Jayakar

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27060988 AND SRC:MED&resulttype=core&format=json

1 April 2020

Pramila Krishnamurthy

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27060988 AND SRC:MED&resulttype=core&format=json

1 April 2020

Michael N Potter

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27060988 AND SRC:MED&resulttype=core&format=json

1 April 2020

Bronwen Shaw

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27060988 AND SRC:MED&resulttype=core&format=json

1 April 2020

Roderick Skinner

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27060988 AND SRC:MED&resulttype=core&format=json

1 April 2020

Andrew Turner

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27060988 AND SRC:MED&resulttype=core&format=json

1 April 2020

Robert F Wynn

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27060988 AND SRC:MED&resulttype=core&format=json

1 April 2020

Peter Coyle

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27060988 AND SRC:MED&resulttype=core&format=json

1 April 2020

Haemato-oncology Task Force of the British Committee for Standards in Haematology

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27060988 AND SRC:MED&resulttype=core&format=json

1 April 2020

British Society for Blood and Marrow Transplantation and the UK Clinical Virology Network

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27060988 AND SRC:MED&resulttype=core&format=json

1 April 2020

language of work or name

0 references

publication date

7 April 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27060988 AND SRC:MED&resulttype=core&format=json

1 April 2020

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27060988 AND SRC:MED&resulttype=core&format=json

1 April 2020

173

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27060988 AND SRC:MED&resulttype=core&format=json

1 April 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27060988 AND SRC:MED&resulttype=core&format=json

1 April 2020

380-393

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27060988 AND SRC:MED&resulttype=core&format=json

1 April 2020

The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Therapy of respiratory viral infections with intranasal siRNAs

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

The response to vaccination against influenza A(H1N1) 2009, seasonal influenza and Streptococcus pneumoniae in adult outpatients with ongoing treatment for cancer with and without rituximab.

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Non-invasive sample collection for respiratory virus testing by multiplex PCR.

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants.

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Viral and bacterial interactions in the upper respiratory tract

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Clinical outcomes associated with respiratory virus detection before allogeneic hematopoietic stem cell transplant

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

How I treat influenza in patients with hematologic malignancies.

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Community respiratory virus infections in bone marrow transplant recipients: the M.D. Anderson Cancer Center experience

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Influenza forecasting in human populations: a scoping review

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Cross-neutralization of four paramyxoviruses by a human monoclonal antibody

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Parainfluenza type 3 infection post stem cell transplant: high prevalence but low mortality

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Evaluation of the antiviral response to zanamivir administered intravenously for treatment of critically ill patients with pandemic influenza A (H1N1) infection.

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Seasonal trends of human parainfluenza viral infections: United States, 1990-2004.

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections.

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Human metapneumovirus in adults

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Prophylactic and therapeutic benefits of a monoclonal antibody against the fusion protein of human metapneumovirus in a mouse model.

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Parainfluenza viruses

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Epidemiology, prevention, and management of influenza in patients with hematologic malignancy

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Rhinovirus Infections in Hematopoietic Stem Cell Transplant Recipients with Pneumonia

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Human rhinoviruses

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

High prevalence of human metapneumovirus subtype B in cases presenting as severe acute respiratory illness: an experience at tertiary care hospital

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Pulmonary infections diagnosed by BAL: a 12-year experience in 1066 immunocompromised patients.

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Treatment of severe human metapneumovirus (hMPV) pneumonia in an immunocompromised child with oral ribavirin and IVIG.

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Incubation periods of acute respiratory viral infections: a systematic review.

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT.

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

The impact of viral genotype on pathogenesis and disease severity: respiratory syncytial virus and human rhinoviruses

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Flocked nasal swab versus nasopharyngeal aspirate for detection of respiratory tract viruses in immunocompromised adults: a matched comparative study

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Palivizumab is highly effective in suppressing respiratory syncytial virus in an immunosuppressed animal model

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Pretransplantation respiratory syncytial virus infection: impact of a strategy to delay transplantation

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinoviruses

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Environmental factors affecting the transmission of respiratory viruses

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Immune modulatory activity of ribavirin for serious human metapneumovirus disease: early i.v. therapy may improve outcomes in immunosuppressed SCT recipients

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Pathogenesis of acute respiratory illness caused by human parainfluenza viruses

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Treatment with oral ribavirin and IVIG of severe human metapneumovirus pneumonia (HMPV) in immune compromised child

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Management of RSV infections in adult recipients of hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections.

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

The human metapneumovirus: a case series and review of the literature

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Successful treatment of parainfluenza virus 3 pneumonia with oral ribavirin and methylprednisolone in a bone marrow transplant recipient

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Long-term therapy with aerosolized ribavirin for parainfluenza 3 virus respiratory tract infection in an infant with severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Comparison of nasopharyngeal aspirate with flocked swab for PCR-detection of respiratory viruses in children

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Human metapneumovirus infections in adults: another piece of the puzzle

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Community respiratory virus infections in immunocompromised patients with cancer

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Treatment of Parainfluenza 3 Infection With DAS181 in a Patient After Allogeneic Stem Cell Transplantation

1 reference

https://api.crossref.org/works/10.1111/BJH.14027

21 January 2018

Human rhinovirus infections of the lower respiratory tract in hematopoietic stem cell transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/27060988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Respiratory distress associated with zanamivir

1 reference

https://pubmed.ncbi.nlm.nih.gov/27060988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuraminidase inhibitors improve outcome of patients with leukemia and influenza: an observational study

1 reference

https://pubmed.ncbi.nlm.nih.gov/27060988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Respiratory viral infections in transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/27060988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Concordance of nasal swabs and nasopharyngeal swabs in the detection of respiratory viruses by direct immunofluorescence]

1 reference

https://pubmed.ncbi.nlm.nih.gov/27060988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/27060988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2013 IDSA clinical practice guideline for vaccination of the immunocompromised host

1 reference

https://pubmed.ncbi.nlm.nih.gov/27060988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40721939&oldid=1505915928"